Enterprise Europe Network

Platform technology that allows the conversion of an assay, lab based protocol or diagnostic into a compact, deployable instrument or sensor using imaging, electrochemical or biosensor based technologies

Country of origin:
External Id: 
Last update
Expiration date


Partner keyword: 
Imaging, Image Processing, Pattern Recognition
Sensor Technology related to measurements
Manufacturing/industrial software
Food & feed ingredients
Other pollution and recycling related
Agriculture, Forestry, Fishing, Animal Husbandry & Related Products
Manufacture of instruments and appliances for measuring, testing and navigation
Technical testing and analysis
Other professional, scientific and technical activities n.e.c.


This UK-based multi-disciplinary engineering and software company has developed a platform technology that allows the conversion of an assay, lab protocol or diagnostic into a compact and deployable instrument or sensor using imaging, electrochemical or biosensor based technologies, thus enabling rapid and widespread deployment of the protocol/assay. It offers this technology to partners under a licence agreement or under a commercial agreement with technical assistance.



Established in 2013, the UK company is a multi-disciplinary engineering and software company, with particular expertise in the fields of electronics, imaging, electrochemical engineering, biosensing and microfluidic-based technologies. It works with other companies, entrepreneurs and universities to produce next generation instrumentation, sensors and software for their needs.

To date, it has developed products and systems for application in sectors ranging from life sciences, agriculture, environment through to industry / manufacturing. It now has a range of core platform technologies that it can combine to develop custom instrumentation, analytical systems, sensors or software for its client’s needs.

During its contacts with researchers in companies and universities over the years, the company has identified that they have often designed a diagnostic test or assay, but require instrumentation and/or software to complement this and to allow an easier and quicker deployment. It has therefore developed a platform technology that allows the conversion of an assay, laboratory protocol or a diagnostic into an instrument or sensor of varying form factor. The instrumentation is compact, low-cost and deployable and can be configured into a wearable, an autonomous standalone sensor or a small palm sized instrument connected to a smartphone, PC or to the cloud.

The technology would suit companies and/or universities who have an existing protocol, assay or laboratory workflow that would benefit from being smaller, lower cost, more autonomous or deployable. This could be an existing product that is on the market, where the partner is looking to develop the next generation, or it could be a new project that is still in the R&D phase and requires such a technology to reach the market.

Examples of possible applications include an environmental sensing solution that could be deployed and work autonomously, a food and feed technology that is able to reach more people or a point-of-sample or a life science assay that needed a sensing technology.

The UK company, with its strong expertise and core platform technologies, is interested in collaborating with such partners on the basis of a licence agreement. Alternatively, a commercial agreement with technical assistance could also be possible. Through this collaboration, the company seeks to deploy its technologies and expertise in new markets and to grow the business.

Advantages & innovations

Cooperation plus value: 
The platform technology offered by the UK company offers the following advantages to a potential partner: • A way of revolutionising an existing assay, protocol or diagnostic by allowing it to be deployed more widely and offering a higher value to users; • The instrumentation is compact and available in a variety of formats, from a wearable to a standalone sensor. It can also be made available as a small instrument connected to a PC, smartphone or the cloud; • Thanks to the fact that the core platform technologies are already developed, they are available at a relatively low cost. Innovations: • The use of innovative sensor and system form factors to allow deployment into different application types; • Embedded software/algorithms to capture responses and convert into SI units (International System of Units); • The ability to integrate multi-disciplinary technologies including microfluidics.

Stage of development

Cooperation stage dev stage: 
Already on the market

Partner sought

Cooperation area: 
Partners could be companies (of any size), universities or research centres who are developing a new assay / diagnostic or lab protocol which has a clear commercial value and opportunity and where routes to market can be established, but who wishes to enhance this through the addition of instrumentation and software to create an imaging, electrochemical or biosenor based solution. Alternatively, they may have an existing assay or diagnostic technology that is already in the market that would suit an alternative technological platform. They would be expected to licence the UK company’s technology for use in their own assay / diagnostic / lab protocol. Another option would be for them to conclude a commercial agreement to incorporate the technology into their own, with the UK company providing appropriate technical assistance.

Type and size

Cooperation task: 
SME 11-50,University,R&D Institution,SME <10,251-500,SME 51-250


Dissemination sector group : 
Dissemination preferred : 
Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland